HanchorBio Presents Phase 1 HCB101 Clinical Results at FACO 2025 Demonstrating Safety and Early Antitumor Activity
FACO 2025 presentation highlights HCB101's favorable safety, strong receptor occupancy, and confirmed responses in patients with advanced cancers. TAIPEI, SHANGHAI, and SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a...
Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability
SHANGHAI and HONG KONG, Oct. 20, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
SIFF 2025: The Premier Launchpad for Chinese Movies and Their Global Promotion
SHANGHAI, June 21, 2025 /PRNewswire/ -- The 27th Shanghai International Film Festival (SIFF) is currently in full swing, vividly demonstrating the booming momentum of Chinese-language movies. Across its five core sections and a series of themed...
Nota AI Achieves 100% Accuracy Through Sony IMX500®-Powered Smart Traffic Solution, Demonstrating Global Competitiveness
On-device AI optimization delivers high-performance AI on Sony's IMX500 chipset with minimal power consumption and cost 100% accuracy achieved in AI Voucher project, recognized as a best-case study in Sony's webinar SEOUL, South Korea, June 13, 2025...